Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Injectable Bandage Stops Bleeding and Promotes Healing

By HospiMedica International staff writers
Posted on 17 Apr 2018
An injectable hydrogel based on kappa-carrageenan (κCA), a natural polysaccharide commonly used as a thickening agent for pastries, can facilitate wound healing, claims a new study.

Developed by researchers at Texas A&M University (TAMU; College Station, TX, USA), the nanoengineered hemostatic hydrogel consist of a κCA gel loaded with synthetic two-dimensional nanosilicates. More...
The nanosilicates, which are similar to clay, hold an ionic charge, thus increasing protein adsorption; this results in enhanced cell adhesion and spread, increased platelet binding, and reduced bloodclotting time. In addition, the nanosilicates allow a range of therapeutic biomacromolecules to be delivered in a sustained manner.

The addition of the nanosilicates also significantly suppresses the release of vascular endothelial growth factor (VEGF) and facilitates tissue regeneration and wound healing. By controlling the ratio between κCA and the nanosilicates, the compressive stiffness of the crosslinked hydrogel can be modulated between 20 and 200 kPa. But even at such high mechanical stiffness, the hydrogel remains highly porous with the interconnected network. The study was published on February 7, 2018, in Acta Biomaterialia.

“Interestingly, we also found that these injectable bandages can show a prolonged release of therapeutics that can be used to heal the wound,” said lead author graduate student Giriraj Lokhande, MSc, of the department of biomedical engineering. “The negative surface charge of nanoparticles enabled electrostatic interactions with therapeutics, thus resulting in the slow release of therapeutics.”

“Injectable hydrogels are promising materials for achieving hemostasis in case of internal injuries and bleeding, as these biomaterials can be introduced into a wound site using minimally invasive approaches,” concluded senior author Akhilesh Gaharwar, PhD. “An ideal injectable bandage should solidify after injection in the wound area and promote a natural clotting cascade. In addition, the injectable bandage should initiate wound healing response after achieving hemostasis.”

Hemorrhage is a leading cause of death in the battlefield, as well as during surgical anastomosis and percutaneous interventions. In addition, approximately 25% of potentially survivable deaths result from uncontrolled junctional bleeding, the leading cause of preventable death in combat and the top focus of tactical medicine. Over 800 U.S. military personnel have been hospitalized with these types of injuries during the wars in Iraq and Afghanistan. Of these, more than 150 suffered from upper extremity injuries, 25 of who died from their wounds.

Related Links:
Texas A&M University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.